The Role of Sodium-Glucose Cotransporter-2 Inhibition in Heart Failure with Preserved Ejection Fraction.
鈉葡萄糖共同轉運蛋白-2抑制在保留射血分數心衰中的角色。
Pharmacy (Basel) 2022-12-27
Sodium-Glucose Cotransporter 2 Inhibitors Among Heart Failure With Mildly Reduced and Preserved Ejection Fraction.
心衰患者中輕度降低和保留射血分數的鈉葡萄糖共轉運蛋白2抑製劑。
Ann Pharmacother 2023-10-18
Effects of Sodium-Glucose Cotransporter Inhibitor Use in Type 2 Diabetes Mellitus Patients With Heart Failure.
二型糖尿病患者合併心臟衰竭使用鈉葡萄糖共同轉運蛋白抑制劑的影響。
Cureus 2023-03-14
The use of sodium-glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: new guidelines hot off the press and directly into guidelines!
新指南即將發布:心衰患者中使用鈉葡萄糖共轉運輸蛋白2抑制劑的指引!
Postgrad Med J 2023-09-25
Chapter 3: Clinical Trials of Sodium-Glucose Co-Transporter-2 Inhibitors for Treatment of Heart Failure.
第三章:用於治療心臟衰竭的鈉葡萄糖共轉運輸蛋白-2抑製劑的臨床試驗。
Am J Med 2024-01-16